Trial NCT03310567

View at ClinicalTrials.gov 
Org. Study IDs: GYN-104

Last trial update was posted on 2018-10-09

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Endometrial Neoplasms Recurrence

Other Conditions

Recurrent/ Metastatic Endometrial Carcinoma

Stopping Reasons

Sponsors pulled out of the study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID